dabigatran etexilate mesylate
SpainDrugs containing this active substance
-
It is used in adults to prevent the formation of blood clots after knee or hip surgery, to prevent stroke in people with an irregular heart rhythm (non-valvular atrial fibrillation), and to treat or prevent clots in the veins of the legs and lungs. In children aged 8 years or older, it is used to treat and prevent the formation of blood clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 126,83 mg Manufacturer: Adamed Laboratorios S.L.U.
-
It is used in adults to prevent the formation of blood clots in the brain and other blood vessels in people with a type of irregular heart rhythm (non-valvular atrial fibrillation) with additional risk factors. It is also used to treat and prevent clots in the veins of the legs and lungs. In children aged 8 years or older, it is used to treat and prevent the formation of clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 172,95 mg Manufacturer: Adamed Laboratorios S.L.U.
-
It is used in adults to prevent blood clots after knee or hip replacement surgery, to prevent stroke in people with an irregular heartbeat (non-valvular atrial fibrillation), and to treat or prevent blood clots in the leg veins and lungs. In children, it is used to treat blood clots and prevent them from reappearing.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 126,83 mg Manufacturer: Laboratorios Alter S.A.
-
It is used in adults to prevent the formation of blood clots in the brain and other blood vessels in people with non-valvular atrial fibrillation. It is also used to treat and prevent the recurrence of blood clots in the veins of the legs and lungs. In children, it is used to treat clots and prevent them from reappearing.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 172,95 mg Manufacturer: Laboratorios Alter S.A.
-
It is used in adults to prevent the formation of blood clots after knee or hip surgery, to prevent stroke in people with an irregular heart rhythm (non-valvular atrial fibrillation), and to treat or prevent blood clots in the leg and lung veins. In children, it is used to treat and prevent the formation of blood clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 126,84 mg Manufacturer: Laboratorios Cinfa S.A.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels if they suffer from non-valvular atrial fibrillation, and to treat and prevent blood clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of blood clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 172,95 mg Manufacturer: Laboratorios Cinfa S.A.
-
It is used in adults to prevent blood clots after knee or hip surgery, to prevent stroke and other clots in people with irregular heart rhythm (non-valvular atrial fibrillation), and to treat or prevent blood clots in the veins of the legs and lungs. In children, it is used to treat and prevent clot formation.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 126,83 mg Manufacturer: Laboratorios Combix S.L.U.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels in people with non-valvular atrial fibrillation, as well as to treat and prevent blood clots in the veins of the legs and lungs. In children, it is used to treat and prevent blood clot formation.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 172,95 mg Manufacturer: Laboratorios Combix S.L.U.
-
It is used in adults to prevent the formation of blood clots following knee or hip surgery, to prevent stroke and other clots in people with an irregular heartbeat (non-valvular atrial fibrillation), and to treat or prevent clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of blood clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 126,87 mg Manufacturer: Krka D.D. Novo Mesto
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels in people with an irregular heart rhythm called non-valvular atrial fibrillation. It is also used to treat and prevent blood clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of these clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 173,01 mg Manufacturer: Krka D.D. Novo Mesto
-
It is used in adults to prevent the formation of blood clots after knee or hip surgery, to prevent stroke in people with an irregular heart rhythm (non-valvular atrial fibrillation), and to treat or prevent blood clots in the leg and lung veins. In children, it is used to treat and prevent the formation of blood clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 126,83 mg Manufacturer: Laboratorios Normon S.A.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels in people with an irregular heart rhythm (non-valvular atrial fibrillation) with risk factors. It is also used to treat and prevent blood clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of blood clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 172,95 mg Manufacturer: Laboratorios Normon S.A.
-
It is used in adults to prevent the formation of blood clots following knee or hip surgery, to prevent stroke in people with an irregular heart rhythm (non-valvular atrial fibrillation), and to treat or prevent clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of these clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 126,83 mg Manufacturer: Towa Pharmaceutical S.A.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels in people with an irregular heart rhythm called non-valvular atrial fibrillation. It is also used to treat and prevent blood clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of blood clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 172,95 mg Manufacturer: Towa Pharmaceutical S.A.
-
It is used in adults to prevent blood clots after knee or hip surgery, to prevent stroke in people with irregular heart rhythm (non-valvular atrial fibrillation), and to treat or prevent blood clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of blood clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 126,83 mg Manufacturer: Galenicum Health S.L.U.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels in people with non-valvular atrial fibrillation, and to treat and prevent blood clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of blood clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 172,95 mg Manufacturer: Galenicum Health S.L.U.
-
It is used in adults to prevent blood clots after knee or hip surgery, to prevent stroke in people with an irregular heart rhythm (non-valvular atrial fibrillation), and to treat or prevent clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of blood clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 126,83 mg Manufacturer: Laboratorio Stada S.L.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels in people with an irregular heart rhythm called non-valvular atrial fibrillation. It is also used to treat and prevent blood clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of these clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 172,95 mg Manufacturer: Laboratorio Stada S.L.
-
In adults, it is used to prevent the formation of blood clots in the veins after knee or hip surgery. In children, it is used to treat blood clots and prevent them from reappearing.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 86,48 mg Manufacturer: Laboratorio Stada S.L.
-
It is used in adults to prevent the formation of blood clots following knee or hip surgery, to prevent stroke and other clots in people with an irregular heart rhythm (non-valvular atrial fibrillation), and to treat or prevent clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of blood clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 126,84 mg Manufacturer: Tecnimede Espana Industria Farmaceutica S.A.
-
It is used in adults to prevent blood clots in the brain (stroke) and other blood vessels in people with an irregular heart rhythm called non-valvular atrial fibrillation. It is also used to treat and prevent blood clots in the veins of the legs and lungs. In children, it is used to treat and prevent blood clot formation.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 172,95 mg Manufacturer: Tecnimede Espana Industria Farmaceutica S.A.
-
It is used in adults to prevent blood clots after knee or hip replacement, to prevent stroke in people with an irregular heart rhythm (non-valvular atrial fibrillation), and to treat or prevent blood clots in the veins of the legs and lungs. In children, it is used to treat clots and prevent them from reappearing.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 126,83 mg Manufacturer: Teva Gmbh
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels in people with non-valvular atrial fibrillation and at least one additional risk factor. It is also used to treat and prevent the recurrence of blood clots in the veins of the legs and lungs. In children, it is used to treat clots and prevent them from reappearing.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 172,95 mg Manufacturer: Teva Gmbh
-
It is used in adults to prevent the formation of blood clots in the veins following knee or hip replacement surgery. In children, it is used to treat blood clots and prevent them from reappearing.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 86,48 mg Manufacturer: Teva Gmbh
-
It is used in adults to prevent the formation of blood clots after knee or hip surgery, to prevent stroke in people with an irregular heart rhythm (non-valvular atrial fibrillation), and to treat or prevent clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of these clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 126,830 mg Manufacturer: Viatris Limited
-
Dabigatran etexilate Viatris is used in adults to prevent the formation of clots in the brain and other blood vessels in people with an irregular heartbeat (non-valvular atrial fibrillation), and to treat and prevent clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of blood clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 172,95 mg Manufacturer: Viatris Limited
-
It is used in children to treat blood clots and to prevent them from forming again.
Form: granules, coated
Active substance Dosage dabigatran etexilate mesylate 126,83 mg Manufacturer: Boehringer Ingelheim International Gmbh
-
It is used in adults to prevent the formation of blood clots following knee or hip surgery, to prevent stroke in people with an irregular heart rhythm (non-valvular atrial fibrillation), and to treat or prevent clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of blood clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 110 mg Manufacturer: Boehringer Ingelheim International Gmbh
-
It is used in adults to prevent the formation of blood clots after knee or hip surgery, to prevent stroke and other clots in people with an irregular heart rhythm (non-valvular atrial fibrillation), and to treat or prevent clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of blood clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 110 mg Manufacturer: Boehringer Ingelheim International Gmbh
-
It is used in adults to prevent the formation of blood clots after knee or hip surgery, to prevent stroke in people with an irregular heart rhythm (non-valvular atrial fibrillation), and to treat or prevent blood clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of blood clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 110 mg Manufacturer: Boehringer Ingelheim International Gmbh
-
It is used in children to treat blood clots and to prevent them from forming again.
Form: granules, coated
Active substance Dosage dabigatran etexilate mesylate 172,95 mg Manufacturer: Boehringer Ingelheim International Gmbh
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels in people with non-valvular atrial fibrillation, and to treat and prevent blood clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of blood clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 172,95 mg Manufacturer: Boehringer Ingelheim International Gmbh
-
It is used in children to treat blood clots and to prevent them from forming again.
Form: granules, coated
Active substance Dosage dabigatran etexilate mesylate 23,06 mg Manufacturer: Boehringer Ingelheim International Gmbh
-
It is used in children to treat blood clots and to prevent them from forming again.
Form: granules, coated
Active substance Dosage dabigatran etexilate mesylate 34,59 mg Manufacturer: Boehringer Ingelheim International Gmbh
-
What is Pradaxa used for?": "It is used in children to treat blood clots and prevent them from forming again.", "How should I administer Pradaxa to my child?": "It should be taken twice a day, one dose in the morning and another at night, approximately every 12 hours. The medication should be mixed with apple juice or soft foods such as carrot puree, applesauce, or banana puree. It must not be mixed with milk or foods containing dairy products.", "When should my child not take Pradaxa?": "It should not be used if the child is allergic to the medication, if they have severely reduced renal function, if they have current bleeding, or if they have organ diseases that increase the risk of bleeding (such as ulcers or brain injuries). It should also not be taken if they have severely reduced hepatic function or if they are receiving certain other medications such as ketoconazole, itraconazole, cyclosporine, dronedarone, or products for hepatitis C.", "What side effects can Pradaxa have?": "The most common effects are related to bleeding, such as bruising, nosebleeds, or gastric reflux. Nausea, vomiting, diarrhea, indigestion, or skin changes may also occur. If the child experiences bleeding that does not stop, extreme weakness, paleness, dizziness, or unexplained swelling, you must consult a doctor immediately.", "What should I do if my child forgets a dose?": "If a dose is forgotten, it can be administered up to 6 hours before the next one. If there are less than 6 hours remaining until the next dose, the missed dose should be skipped. A double dose should not be administered to compensate.", "What precautions should I take if my child is having surgery?": "Pradaxa must be temporarily discontinued before a surgical procedure due to the increased risk of bleeding. It is essential to follow the doctor's instructions exactly regarding when to stop and when to resume it.", "How should I store the medication?": "It must be kept out of the sight and reach of children. Once the aluminum pouch containing the sachets is opened, the medication must be used within the following 6 months."
Form: granules, coated
Active substance Dosage dabigatran etexilate mesylate 46,12 mg Manufacturer: Boehringer Ingelheim International Gmbh
-
What is Pradaxa used for?": "It is used in children to treat blood clots and to prevent them from forming again.", "How should I administer Pradaxa to my child?": "It should be taken twice a day, one dose in the morning and another at night, approximately every 12 hours. The medication should be administered before meals, mixed with apple juice or with soft foods such as carrot puree, applesauce, or banana puree. It must not be mixed with milk or foods containing dairy products.", "When should this medication not be used?": "It should not be used if the child is allergic to its components, if they have significantly reduced renal function, if they have current bleeding, or if they have organ diseases that increase the risk of serious bleeding (such as stomach ulcers or brain injuries). It should also not be used if the child has a natural tendency to bleed or if they are receiving other medications to prevent clots (such as warfarin, heparin, etc.), unless specifically instructed by a doctor.", "What should I do if my child misses a dose?": "If a dose is missed, it can be administered up to 6 hours before the next one. If there are less than 6 hours remaining until the next dose, the missed dose should be skipped. Do not administer a double dose to compensate.", "What are the side effects of Pradaxa?": "As an anticoagulant, the most common side effects are related to bleeding, such as bruising, nosebleeds, or bleeding in the stomach, intestine, or urinary tract. Other frequent effects include nausea, vomiting, indigestion, diarrhea, skin rash, or hair loss. You must consult a doctor immediately if you notice signs of excessive bleeding such as extreme weakness, paleness, dizziness, or headache.", "What other medications may interact with Pradaxa?": "The doctor must be informed if the child is taking medications for blood clotting, for fungal infections (such as ketoconazole), for heart rhythm, to prevent organ rejection, antivirals for hepatitis C or AIDS, anti-inflammatories (such as ibuprofen or diclofenac), or certain antidepressants and antibiotics.", "What precautions should I take if my child needs surgery?": "Pradaxa must be temporarily discontinued before a surgical procedure due to the increased risk of hemorrhage. It is essential to follow the doctor's instructions exactly regarding when to stop and when to resume it. If epidural or spinal anesthesia is used, inform the doctor immediately if the child experiences weakness or numbness in the legs."
Form: granules, coated
Active substance Dosage dabigatran etexilate mesylate 57,65 mg Manufacturer: Boehringer Ingelheim International Gmbh
-
It is used in adults to prevent the formation of blood clots in the veins after knee or hip surgery. In children, it is used to treat blood clots and prevent them from reappearing.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 75 mg Manufacturer: Boehringer Ingelheim International Gmbh
-
It is used in adults to prevent the formation of blood clots in the veins after knee or hip surgery. In children, it is used to treat blood clots and prevent them from reappearing.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 75 mg Manufacturer: Boehringer Ingelheim International Gmbh
-
It is used in adults to prevent the formation of blood clots after knee or hip surgery, to prevent stroke in people with an irregular heart rhythm (non-valvular atrial fibrillation), and to treat or prevent clots in the leg and lung veins. In children, it is used to treat and prevent the formation of blood clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 126,830 mg Manufacturer: Kern Pharma S.L.
-
It is used in adults to prevent the formation of blood clots in the brain (stroke) and other blood vessels in people with an irregular heart rhythm called non-valvular atrial fibrillation. It is also used to treat and prevent clots in the veins of the legs and lungs. In children, it is used to treat and prevent the formation of blood clots.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 172,95 mg Manufacturer: Kern Pharma S.L.
-
In adults, it is used to prevent the formation of blood clots in the veins after knee or hip surgery. In children, it is used to treat blood clots and prevent them from reappearing.
Form: capsules, hard
Active substance Dosage dabigatran etexilate mesylate 86,48 mg Manufacturer: Kern Pharma S.L.